Page 32 - MI-2-1

Microbes & Immunity Microbial involvement in ME/CFS

transcriptionally active bacteria throughout the 34. Dalile B, Van Oudenhove L, Vervliet B, Verbeke K.
gastrointestinal tract of healthy individuals. Gastroenterology. The role of short-chain fatty acids in microbiota-gut-
2019;157(4):1081-1092.e3. brain communication. Nat Rev Gastroenterol Hepatol.
2019;16:461-478.
doi: 10.1053/j.gastro.2019.05.068
doi: 10.1038/s41575-019-0157-3
23. Borrego-Ruiz A, Borrego JJ. Human gut microbiome, diet,
and mental disorders. Int Microbiol. 2024. 35. Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty
acids from gut microbiota in gut-brain communication.
doi: 10.1007/s10123-024-00518-6
Front Endocrinol (Lausanne). 2020;11:25.
24. Iizumi T, Battaglia T, Ruiz V, Perez Perez GI. Gut microbiome doi: 10.3389/fendo.2020.00025
and antibiotics. Arch Med Res. 2017;48(8):727-734.
36. Qian XH, Xie RY, Liu XL, Chen SD, Tang HD. Mechanisms
doi: 10.1016/j.arcmed.2017.11.004 of short-chain fatty acids derived from gut microbiota in
25. Tanaka M, Nakayama, J. Development of the gut microbiota Alzheimer’s disease. Aging Dis. 2022;13(4):1252-1266.
in infancy and its impact on health in later life. Allergol Int. doi: 10.14336/AD.2021.1215
2017;66(4):515-522.
37. Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-
doi: 10.1016/j.alit.2017.07.010 modulated metabolites at the interface of host immunity.
26. Das B, Nair GB. Homeostasis and dysbiosis of the gut J Immunol. 2017;198(2):572-580.
microbiome in health and disease. J Biosci. 2019;44(5):117. doi: 10.4049/jimmunol.1601247
doi: 10.1007/s12038-019-9926-y 38. Salami M. Interplay of good bacteria and central nervous
27. Brestoff JR, Artis D. Commensal bacteria at the interface system: Cognitive aspects and mechanistic considerations.
of host metabolism and the immune system. Nat Immunol. Front Neurosci. 2021;15:613120.
2013;14(7):676-684. doi: 10.3389/fnins.2021.613120
doi: 10.1038/ni.2640 39. Vogl T, Kalka IN, Klompus S, Leviatan S, Weinberger A,
28. Hou K, Wu ZX, Chen XY, et al. Microbiota in health and Segal E. Systemic antibody responses against human
diseases. Signal Transduct Target Ther. 2022;7(1):135. microbiota flagellins are overrepresented in chronic fatigue
syndrome patients. Sci Adv. 2022;8(38):eabq2422.
doi: 10.1038/s41392-022-00974-4
doi: 10.1126/sciadv.abq2422
29. Yin R, Kuo HC, Hudlikar R, et al. Gut microbiota, dietary
phytochemicals and benefits to human health. Curr 40. Shukla SK, Cook D, Meyer J, et al. Changes in gut and
Pharmacol Rep. 2019;5:332-344. plasma microbiome following exercise challenge in Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
doi: 10.1007/s40495-019-00196-3 PLoS One. 2015;10(12):e0145453.
30. Rooks MG, Garrett WS. Gut microbiota, metabolites and doi: 10.1371/journal.pone.0145453
host immunity. Nat Rev Immunol. 2016;16(6):341-352.
41. Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR.
doi: 10.1038/nri.2016.42 The association of fecal microbiota and fecal, blood serum
31. Keszthelyi D. Histamine-producing bacteria: The missing and urine metabolites in myalgic encephalomyelitis/chronic
link in irritable bowel syndrome? Gastroenterology. fatigue syndrome. Metabolomics. 2017;13(1):8.
2023;164(1):160-161. doi: 10.1007/s11306-016-1145-z
doi: 10.1053/j.gastro.2022.08.053 42. Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE,
32. Ruan W, Engevik MA, Spinler JK, Versalovic J. Healthy Hanson MR. Reduced diversity and altered composition
human gastrointestinal microbiome: Composition of the gut microbiome in individuals with myalgic
and function after a decade of exploration. Dig Dis Sci. encephalomyelitis/chronic fatigue syndrome. Microbiome.
2020;65(3):695-705. 2016;4(1):30.
doi: 10.1007/s10620-020-06118-4 doi: 10.1186/s40168-016-0171-4
33. Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I 43. Mandarano AH, Giloteaux L, Keller BA, Levine SM,
interferons and microbial metabolites of tryptophan Hanson MR. Eukaryotes in the gut microbiota in myalgic
modulate astrocyte activity and central nervous system encephalomyelitis/chronic fatigue syndrome. PeerJ.
inflammation via the aryl hydrocarbon receptor. Nat Med. 2018;6:e4282.
2016;22(6):586-597. doi: 10.7717/peerj.4282
doi: 10.1038/nm.4106 44. Kitami T, Fukuda S, Kato T, et al. Deep phenotyping of

Volume 2 Issue 1 (2025) 24 doi: 10.36922/mi.4783